<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02275091</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0755</org_study_id>
    <nct_id>NCT02275091</nct_id>
  </id_info>
  <brief_title>Children With Diabetes at Risk for Heart Disease.</brief_title>
  <official_title>Identifying Children With Diabetes Type 1 at High Risk for Cardiovascular Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Howard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with type 1 diabetes type 1 (DM1) have increased risk of death due to heart disease
      and stroke. These cardiovascular conditions (CVD) are the leading cause of death in patients
      with DM1 younger than 40 years of age and up to 35% of all persons with DM1 will die before
      age 55 from CVD. Strategies are needed to help identify adolescents with DM1 at risk for CVD
      so that interventions to prevent heart disease and stroke can be undertaken.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with type 1 diabetes and healthy controls will have evaluation of their lipid
      profile. Arterial stiffness, heart rate variability and adiposity measurements will be done
      in patients with type 1 diabetes and healthy controls. Blood pressure and heart rate will be
      recorded. 50 ml of urine will be collected from patients and controls.

      All studies will be performed as a single outpatient visit at Georgetown University.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>small LDL particles</measure>
    <time_frame>This is an observational cross sectional study. Samples will be collected through study completion, on average of 6 years duration.</time_frame>
    <description>Blood test, based on NMR</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Diabetes Complications</condition>
  <arm_group>
    <arm_group_label>Diabetes</arm_group_label>
    <description>Children with diabetes type 1 , 12-21 years old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy children 12-21 years old</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples will be collected through study completion
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children with diabetes type 1 and healthy children
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diabetes type 1 or Healthy

        Exclusion Criteria:

        Taking medications that lower cholesterol Duration of type 1 diabetes &lt; 1 year.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evgenia Gourgari</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georgetown University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evgenia Gourgari, MD</last_name>
    <phone>2024441210</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathryn Turner</last_name>
    <phone>2024442639</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Georgetown-Howard Universities Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Gubb</last_name>
      <phone>202-444-1210</phone>
    </contact>
    <investigator>
      <last_name>Evgenia Gourgari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 23, 2014</study_first_submitted>
  <study_first_submitted_qc>October 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2014</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Georgetown University</investigator_affiliation>
    <investigator_full_name>Evgenia Gourgari, M.D.</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatric Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Diabetes Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

